RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $150,000 | -5.1% | 92,246 | -53.6% | 0.00% | – |
| Q2 2022 | $158,000 | -65.9% | 198,712 | -22.7% | 0.00% | -100.0% |
| Q1 2022 | $463,000 | +5.2% | 257,090 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $440,000 | +10.0% | 257,090 | +32.6% | 0.00% | 0.0% |
| Q3 2021 | $400,000 | +19.0% | 193,944 | +33.4% | 0.00% | – |
| Q2 2021 | $336,000 | +17.5% | 145,374 | +41.7% | 0.00% | – |
| Q1 2021 | $286,000 | -2.1% | 102,623 | 0.0% | 0.00% | – |
| Q4 2020 | $292,000 | -63.3% | 102,623 | +5.3% | 0.00% | -100.0% |
| Q1 2020 | $796,000 | -83.4% | 97,455 | -62.8% | 0.00% | -33.3% |
| Q4 2019 | $4,800,000 | +212.3% | 261,904 | +88.8% | 0.00% | +50.0% |
| Q3 2019 | $1,537,000 | – | 138,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |